1 / 10

Prognostic Significance of Zinc Transporters in Cancer: Survival Analysis Using Kaplan-Meier Plots

This study evaluates the prognostic value of ZIP3, ZIP6, ZIP7, ZIP9, ZIP10, ZIP11, ZnT8, and ZnT9 expression levels in cancer cohorts using Kaplan-Meier analyses and Log-rank tests.

drago
Download Presentation

Prognostic Significance of Zinc Transporters in Cancer: Survival Analysis Using Kaplan-Meier Plots

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1

  2. Supplementary Figure 2

  3. Supplementary Figure 3 Supplementary Figure 3. Kaplan-Meier analyses of overall survival according to ZIP3 expression level. Discriminative power of ZIP3 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  4. Supplementary Figure 4 Supplementary Figure 4. Kaplan-Meier analyses of overall survival according to ZIP6 expression level. Discriminative power of ZIP6 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  5. Supplementary Figure 5 Supplementary Figure 5. Kaplan-Meier analyses of overall survival according to ZIP7 expression level. Discriminative power of ZIP7 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  6. Supplementary Figure 6 Supplementary Figure 6. Kaplan-Meier analyses of overall survival according to ZIP9 expression level. Discriminative power of ZIP9 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  7. Supplementary Figure 7 Supplementary Figure 7. Kaplan-Meier analyses of overall survival according to ZIP10 expression level. Discriminative power of ZIP10 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  8. Supplementary Figure 8 Supplementary Figure 8. Kaplan-Meier analyses of overall survival according to ZIP11 expression level. Discriminative power of ZIP10 in CGCA cohort (A, B, C) were assessed with Kaplan-Meier plotting method and Log-rank test.

  9. Supplementary Figure 9 Supplementary Figure 9. Kaplan-Meier analyses of overall survival according to ZnT8 expression level. Discriminative power of ZnT8 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

  10. Supplementary Figure 10 Supplementary Figure 10. Kaplan-Meier analyses of overall survival according to ZnT9 expression level. Discriminative power of ZnT9 in CGCA cohort (A, B, C) and REMBRANDT cohort (D, E, F) were assessed with Kaplan-Meier plotting method and Log-rank test.

More Related